HARVARD BIOSCIENCE, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $5.51 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2023-03-09
- HARVARD BIOSCIENCE, INC. share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2022 was $5.51, a 0.00% change from fiscal 2021.
- HARVARD BIOSCIENCE, INC. share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2021 was $5.51, a 2.13% decline from fiscal 2020.
- HARVARD BIOSCIENCE, INC. share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2020 was $5.63, a 2.60% decline from fiscal 2019.
- HARVARD BIOSCIENCE, INC. share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2019 was $5.78.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|
| 2022-12-31 | $5.51 10-K · filed 2023-03-09 |
| 2021-12-31 | $5.51 10-K · filed 2022-03-11 |
| 2020-12-31 | $5.63 10-K/A · filed 2021-03-17 |
| 2019-12-31 | $5.78 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |